Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study
- PMID: 26836181
- DOI: 10.3233/JAD-150869
Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study
Abstract
Background: The Neuropsychiatric Inventory (NPI) comprises 12 items, which were conventionally determined by psychopathological symptoms of patients with dementia. The clinical rating scales with structured questionnaires have been useful to evaluate neuropsychiatric symptoms (NPSs) of patients with dementia over the past twenty year.
Objective: The aim of this study was to classify the conventional NPSs in patients with Alzheimer's disease (AD) requiring antipsychotic treatment for their NPSs into distinct clusters to simplify assessment of these numerous symptoms.
Methods: Twelve items scores (product of severity and frequency of each symptom) in the NPI taken from the baseline visit were classified into subgroups by principle component analysis using data from 421 outpatients with AD enrolled in the Clinical Antipsychotic Trials of Intervention Effectiveness-Alzheimer's Disease (CATIE-AD) Phase 1. Chi square tests were conducted to examine the co-occurrence of the subgroups.
Results: We found four distinct clusters: aggressiveness (agitation and irritabilities), apathy and eating problems (apathy and appetite/eating disturbance), psychosis (delusions and hallucinations), and emotion and disinhibition (depression, euphoria, and disinhibition). Anxiety, aberrant motor behavior, and sleep disturbance were not included by these clusters. Apathy and eating problems, and emotion and disinhibition co-occurred (p = 0.002), whereas aggressiveness and psychosis occurred independent of the other clusters.
Conclusions: Four distinct category clusters were identified from NPSs in patients with AD requiring antipsychotic treatment. Future studies should investigate psychosocial backgrounds or risk factors of each distinct cluster, in addition to their longitudinal course over treatment intervention.
Keywords: Alzheimer’s disease; delusions; neuropsychiatric symptoms; principal component analysis.
Similar articles
-
Psychosocial or clinico-demographic factors related to neuropsychiatric symptoms in patients with Alzheimer's disease needing interventional treatment: analysis of the CATIE-AD study.Int J Geriatr Psychiatry. 2017 Dec;32(12):1264-1271. doi: 10.1002/gps.4607. Epub 2016 Oct 7. Int J Geriatr Psychiatry. 2017. PMID: 27714849
-
Baseline Predictors of Antipsychotic Treatment Continuation and Response at Week 8 in Patients with Alzheimer's Disease with Psychosis or Aggressive Symptoms: An Analysis of the CATIE-AD Study.J Alzheimers Dis. 2017;60(1):263-272. doi: 10.3233/JAD-170412. J Alzheimers Dis. 2017. PMID: 28800334
-
Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease.Psychogeriatrics. 2015 Dec;15(4):242-7. doi: 10.1111/psyg.12108. Epub 2015 Mar 3. Psychogeriatrics. 2015. PMID: 25737233
-
Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies.CNS Neurosci Ther. 2016 Mar;22(3):159-66. doi: 10.1111/cns.12484. Epub 2016 Jan 18. CNS Neurosci Ther. 2016. PMID: 26778658 Free PMC article. Review.
-
Psychosis and antipsychotic medications in Alzheimer's disease: clinical management and research perspectives.Dement Geriatr Cogn Disord. 2004;17(1-2):78-90. doi: 10.1159/000074279. Epub 2003 Oct 17. Dement Geriatr Cogn Disord. 2004. PMID: 14566100 Review.
Cited by
-
Blocking beta 2-adrenergic receptor inhibits dendrite ramification in a mouse model of Alzheimer's disease.Neural Regen Res. 2017 Sep;12(9):1499-1506. doi: 10.4103/1673-5374.215261. Neural Regen Res. 2017. PMID: 29089997 Free PMC article.
-
Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?Curr Neurol Neurosci Rep. 2018 Oct 15;18(12):91. doi: 10.1007/s11910-018-0907-6. Curr Neurol Neurosci Rep. 2018. PMID: 30324260 Review.
-
Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2. Cochrane Database Syst Rev. 2021. PMID: 34918337 Free PMC article.
-
Assessing the Stability of Clusters of Neuropsychiatric Symptoms in Alzheimer's Disease and Mild Cognitive Impairment.Curr Alzheimer Res. 2024;21(4):258-275. doi: 10.2174/0115672050309014240705113444. Curr Alzheimer Res. 2024. PMID: 39021180
-
Appetite, Metabolism and Hormonal Regulation in Normal Ageing and Dementia.Diseases. 2018 Jul 20;6(3):66. doi: 10.3390/diseases6030066. Diseases. 2018. PMID: 30036957 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous